A study by the government agency SAMHSA indicated there were approximately 254,000 patients receiving methadone for opioid addiction in 2006. In 2015, it is most likely that number is much higher given the prevalence of opioid addiction and the continued expansion of outpatient opioid treatment services in the United States. Today, there are considerably more methadone clinics and suboxone-approved physicians than there were a decade ago.
Making a new start with medication-assisted treatment is what hundreds of people across the country are deciding to do for themselves every week. Addiction is a progressive illness – one in which a person’s ability to choose is severely compromised. Medication-assisted treatment using either methadone or buprenorphine (suboxone) provides an important open door to a more responsible, quality life.
A majority of individuals suffering with opioid addiction (particularly when the illness spans years) have experienced dramatic brain changes which deepened their physiological dependency on opiates. This physical dependency is not easily removed. It is severe and persistent thus leading the person to do whatever is necessary to avoid being sick from opioid withdrawal.
Most long-term addicted individuals will tell you they rarely, if ever, get high from the illicit substances they use. They are simply trying to avoid being sick from debilitating opioid withdrawal symptoms. When a patient chooses to receive methadone or buprenorphine under the supervision of a doctor, they are making a decision to face their illness and to do something constructive about it.
As a family or friend, it is very helpful to gain an understanding of addiction and how medication-assisted treatment can be life changing for a person stuck in the cycle of opiate addiction.
Making a new start can be a bit frightening. Will methadone work for me? Will my loved ones condemn me? What about my job, or my legal situation? It becomes easy to put off making a decision when so many questions come into play.
It is important to remember that the road to recovery begins with just one step forward. That step will lead to another and another. This new start is always available. The message is one of hope and opportunity. Opiate addiction is a treatable illness. Medication-assistance can make a real difference.
Posted in Addiction Treatment, Drug Treatment, Medication Assisted Treatment, Methadone, Methadone Clinics, Methadone Maintenance, Methadone Programs, Methadone Success, Methadone Treatment, Opiate Treatment, Recovery, Suboxone, Suboxone Doctors, Suboxone Physicians
Tagged MAT, medication-assistance, medication-assisted treatment
Acadia is a large U.S. based company who provide a broad range of behavioral healthcare services that target mental health and substance abuse problems in children, teenagers, and adults.
Their inpatient facilities provide approximately 9200 beds in 37 states including the United States, United Kingdom, and Puerto Rico. The company’s outpatient addiction services specialize in opioid addiction and medication-assisted treatment for those suffering with heroin and other opioid dependencies. Each Acadia clinic utilizes methadone and suboxone in their overall treatment.
Acadia recently acquired CRC Health Group and in so doing raised their total number of opioid treatment programs to about 90 – currently making them the single largest provider in the United States.
Acadia just added 10 more clinics to Methadone.US and site visitors can find more information about Acadia’s Opioid Treatment Programs by visiting these recently added cities on the Methadone.US website:
- Clarksburg, WV
- Galax, VA
- LaVale, MD
- Bothell, WA
- Indianapolis, IN
- Fayetteville, NC
- Roanoke, VA
- Charleston, WV
- Santa Ana, CA
- Chattanooga, TN
- San Diego, CA
- Riverside, CA
- Portland, OR
- Louisville, KY
- Baltimore, MD
Posted in Addiction Recovery, California Drug Treatment, Drug Rehab Programs, Heroin, Medication Assisted Treatment, Methadone, Methadone Benefits, Methadone Clinics, Methadone Maintenance, Methadone Programs, Methadone Treatment, Recovery, Suboxone, Suboxone Clinics, Suboxone Doctors
Tagged Acadia, behavioral healthcare, medication-assisted treatment, opioid treatment
Acadia Healthcare is a leading behavioral healthcare services provider headquartered out of Franklin, Tennessee. The company was established in 2005 and has experienced rapid growth as a result of strategic acquisitions and a sharp focus on the delivery of psychiatric and chemical dependency treatment services.
Acadia recently bought out CRC Health Group for a reported $1.2 billion in a well-publicized sale which closed in February 2015. The acquisition significantly expanded Acadia’s opioid addiction treatment capabilities adding approximately 82 methadone/suboxone facilities nationwide. The company is nicely positioned to serve tens of thousands of patients on a daily basis who are struggling with opioid addiction and other associated illnesses. Methadone and buprenorphine products are utilized in association with a variety of counseling approaches.
Just added to Methadone.US are five of Acadia’s opioid treatment clinics located in San Diego, Riverside, Baltimore, Portland, and Southern Indiana.
Acadia’s mission statement:
Acadia Healthcare’s mission is to create behavioral health centers where people receive care that enables them to regain hope in a supportive, caring environment.
The company presently has behavioral healthcare facilities in 37 U.S. states, the United Kingdom, and Puerto Rico. These include residential treatment centers, inpatient psychiatric hospitals, outpatient clinics, and therapeutic school-based programs.
Posted in Addiction Treatment, Buprenorphine, Drug Rehab Programs, Methadone, Methadone Clinics, Methadone Maintenance, Methadone Programs, Methadone Success, Methadone Treatment, Opiate Addiction, Opiate Treatment, Suboxone, Suboxone Clinics, Suboxone Doctors
Tagged Acadia, CRC Health
Paul LePage, the governor of Maine, has announced that he is considering ceasing state-funded support for methadone. As an alternative, Maine is proposing that patients prescribed methadone be switched to a more affordable suboxone option as part of a $727,000 state budget cut. The story is here.
This is an indefensible decision with dire medical implications for opioid addicted patients currently receiving methadone. It equates to government officials making medical decisions that will negatively impact the health and well-being of thousands of people.
Representative Drew Gattine (a member of the Health & Human Services Committee) is quoted as saying the proposal shows a lack of understanding of the societal costs of addiction throughout the state of Maine.
Methadone and suboxone are both effective medications, but offer very unique characteristics and applications depending on the severity & chronicity of a patient’s opioid addiction. Buprenorphine (the actual opioid agonist contained in suboxone) has a much lower ceiling effect than does methadone meaning its effectiveness would be insufficient for a potentially large percentage of stable methadone patients on 60mg or more of methadone daily. Many patients on a moderate to high maintenance dose of methadone would not have their opioid withdrawal symptoms managed by even the maximum dosage allowed for suboxone – which is generally around 32 mg per day.
For a politician to, in essence, prescribe inappropriate medical treatment for a diagnosable medical condition is a huge state liability. The repercussions are alarming. Hopefully, the local medical establishment and other state officials will step in before irreversible damage is done. Methadone works. This cannot be denied.
Methadone has a long, proven track record of medical efficacy and cost effectiveness. Maine, in particular, has suffered in recent years with a severe opioid addiction epidemic. Reducing access to appropriate medical treatment like methadone will likely result in overdose deaths across Maine and an explosion of condemnation for the governor and his office.
Medication-assisted treatment (MAT) for opioid addiction is not a fad. It is scientifically proven effective and endorsed by multiple state & federal regulatory agencies as well as ASAM.
Posted in Addiction Treatment, Buprenorphine, Drug Treatment, Medication Assisted Treatment, Methadone, Methadone Clinics, Methadone Programs, Methadone Treatment, Opiate Treatment, Recovery, Suboxone, Suboxone Doctors
Tagged LePage, Main
SMC Recovery based in Scottsdale, Arizona opened an outpatient addiction treatment program late last year. SMC provides a Medication-Assisted Program utilizing methadone and an Intensive Outpatient Program. Both treatment modalities are endorsed by SAMHSA as best practices in the field of addiction treatment.
Methadone programs across the USA cover a wide range of prices sometimes as high as $15.00 per day. However, SMC Recovery have implemented one of the most affordable rates in the country at just $55.00 per week. This is an outstanding value for anyone who has been struggling with opiate addiction and it is one of the most competitive rates we have learned of anywhere in the country.
Prospective patients are often unable to get started with outpatient methadone treatment because the cost is just too high for them. SMC Recovery have lowered this barrier considerably. We were informed by their staff that this price will most likely be active over the next year consequently providing numerous Scottsdale area patients an excellent opportunity to see if methadone treatment is beneficial in addressing their addiction problem. SMC’s program offers counseling & support in addition to methadone dosing.
For more information, visit the SMC Recovery website or contact their staff at: 1-480-998-HOPE (4673).